Does diabetic peripheral neuropathic pain (DPNP) disrupt your daily life and keep you awake at night despite your current treatment? You are not alone. The NEPTUNE-17 clinical trial, hosted by the Foundation for Peripheral Neuropathy Research Impact’s partner, GSK, offers a potential new option for managing DPNP symptoms. You may be eligible to participate in the trial if you: You will also need […]
Read More… from Join the NEPTUNE-17 clinical trial for Diabetic Peripheral Neuropathic Pain (DPNP)